cystatin C (New York University/Nathan Kline Institute)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namecystatin C (New York University/Nathan Kline Institute)
Drug Alias Namehuman cystatin-C
ClassificationNatural product/ExtractBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCathepsin B inhibitors
TargetsCathepsin B
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNew York University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNew York University
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A